Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.7 |
No. of shares | m | 256.78 |
1 Week | % | 3.9 |
1 Month | % | 15.4 |
1 Year | % | 58.2 |
52 week H/L | Rs | 107.5/59.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALEMBIC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 62 | 65 | 123 | 143 | 87 | |
Low | Rs | 36 | 25 | 32 | 72 | 56 | |
Sales per share (Unadj.) | Rs | 4.8 | 2.9 | 2.9 | 3.0 | 5.0 | |
Earnings per share (Unadj.) | Rs | 1.6 | 3.6 | 0.5 | 3.4 | 3.1 | |
Diluted earnings per share | Rs | 1.6 | 3.6 | 0.5 | 3.4 | 3.1 | |
Cash flow per share (Unadj.) | Rs | 1.7 | 3.7 | 0.7 | 3.5 | 3.4 | |
Dividends per share (Unadj.) | Rs | 0.20 | 0.60 | 0.20 | 1.80 | 2.20 | |
Adj. dividends per share | Rs | 0.20 | 0.60 | 0.20 | 1.80 | 2.20 | |
Avg Dividend yield | % | 0.4 | 1.3 | 0.3 | 1.7 | 3.1 | |
Book value per share (Unadj.) | Rs | 47.1 | 55.2 | 89.5 | 97.2 | 80.9 | |
Adj. book value per share | Rs | 47.1 | 55.2 | 89.5 | 97.2 | 80.9 | |
Shares outstanding (eoy) | m | 256.78 | 256.78 | 256.78 | 256.78 | 256.78 | |
Price / Sales ratio | x | 10.2 | 15.6 | 27.0 | 35.3 | 14.4 | |
Avg P/E ratio | x | 30.7 | 12.4 | 143.5 | 32.1 | 22.7 | |
P/CF ratio (eoy) | x | 28.8 | 12.0 | 111.7 | 30.4 | 21.0 | |
Price / Book Value ratio | x | 1.0 | 0.8 | 0.9 | 1.1 | 0.9 | |
Dividend payout | % | 12.5 | 16.6 | 37.1 | 53.6 | 70.1 | |
Avg Mkt Cap | Rs m | 12,608 | 11,523 | 19,868 | 27,643 | 18,298 | |
Total wages/salary | Rs m | 205 | 208 | 226 | 215 | 240 |
ALEMBIC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,238 | 739 | 735 | 782 | 1,272 | |
Other income | Rs m | 302 | 935 | 109 | 892 | 643 | |
Total revenues | Rs m | 1,540 | 1,675 | 844 | 1,674 | 1,915 | |
Gross profit | Rs m | 174 | 31 | 104 | 139 | 297 | |
Depreciation | Rs m | 26 | 32 | 39 | 49 | 67 | |
Interest | Rs m | 2 | 3 | 4 | 4 | 5 | |
Profit before tax | Rs m | 447 | 932 | 170 | 979 | 868 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 36 | 1 | 32 | 117 | 62 | |
Profit after tax | Rs m | 411 | 930 | 138 | 862 | 806 | |
Gross profit margin | % | 14.0 | 4.2 | 14.2 | 17.8 | 23.4 | |
Effective tax rate | % | 8.0 | 0.1 | 18.8 | 11.9 | 7.1 | |
Net profit margin | % | 33.2 | 125.8 | 18.8 | 110.2 | 63.4 |
ALEMBIC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 987 | 1,628 | 1,021 | 1,433 | 1,721 | |
Current liabilities | Rs m | 488 | 458 | 594 | 678 | 838 | |
Net working cap to sales | % | 40.3 | 158.3 | 58.1 | 96.6 | 69.4 | |
Current ratio | x | 2.0 | 3.6 | 1.7 | 2.1 | 2.1 | |
Inventory Days | Days | 2,952 | 5,596 | 10,191 | 10,346 | 5,038 | |
Debtors Days | Days | 398 | 444 | 686 | 710 | 673 | |
Net fixed assets | Rs m | 11,671 | 13,079 | 23,069 | 24,886 | 20,324 | |
Share capital | Rs m | 514 | 514 | 514 | 514 | 514 | |
"Free" reserves | Rs m | 11,572 | 13,667 | 22,457 | 24,452 | 20,267 | |
Net worth | Rs m | 12,085 | 14,180 | 22,970 | 24,966 | 20,780 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 12,658 | 14,707 | 24,090 | 26,320 | 22,046 | |
Interest coverage | x | 207.8 | 324.5 | 48.1 | 252.6 | 187.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.1 | 0.1 | 0 | 0 | 0.1 | |
Return on assets | % | 3.3 | 6.3 | 0.6 | 3.3 | 3.7 | |
Return on equity | % | 3.4 | 6.6 | 0.6 | 3.5 | 3.9 | |
Return on capital | % | 3.7 | 6.6 | 0.8 | 3.9 | 4.2 | |
Exports to sales | % | 2.5 | 2.2 | 1.5 | 2.0 | 1.2 | |
Imports to sales | % | 31.2 | 18.6 | 6.1 | 0.3 | 2.4 | |
Exports (fob) | Rs m | 30 | 16 | 11 | 16 | 16 | |
Imports (cif) | Rs m | 386 | 138 | 45 | 2 | 30 | |
Fx inflow | Rs m | 30 | 16 | 11 | 16 | 16 | |
Fx outflow | Rs m | 387 | 138 | 45 | 2 | 30 | |
Net fx | Rs m | -357 | -121 | -34 | 13 | -14 |
ALEMBIC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 215 | 65 | -22 | -177 | 389 | |
From Investments | Rs m | 717 | 567 | -349 | 188 | 73 | |
From Financial Activity | Rs m | -920 | -64 | -154 | -58 | -464 | |
Net Cashflow | Rs m | 12 | 569 | -524 | -47 | -2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Chirayu Amin | COMP SEC: Drigesh Mittal | YEAR OF INC: 1907 | BSE CODE: 506235 | FV (Rs): 2 | DIV YIELD (%): 2.3 |
Read: ALEMBIC 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare ALEMBIC With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.